Nurith Aizenman
[Copyright 2024 NPR]
-
Pharmaceutical companies Pfizer and Merck have agreed to allow generic manufacturers to make inexpensive versions of their anti-viral pills to treat COVID-19.
-
Wealthy countries keep buying way more doses than they need. New data shows just how much the stockpile of unused vaccine is growing.
-
There's been a massive ramp up in production of COVID-19 vaccines. Yet low income nations still aren't getting enough. Analysts say it's because wealthy countries are buying way more than they need.
-
It's the first step in an audacious plan to solve vaccine inequity by setting up the manufacturing of mRNA vaccines across low-resource countries. -
A consortium in South Africa wants to teach manufacturers in poor countries to make Moderna's COVID vaccine. But Moderna won't share its process. So the scientists are trying to reverse engineer it.
-
President Biden has unveiled a plan to vaccinate 70% of the world's population over the next year. But what will it take to get other rich countries on board? And is the goal ambitious enough?
-
President Biden announced an effort to vaccinate 70% of the world's population against COVID by this time 2022. Health officials from lower income countries say they need more than donations of doses.
-
She's had to flee Afghanistan for her life. And she's one of many whose experience offers a window into what the Taliban takeover may hold for the country's women. -
She's one of 110 girls in a boarding program run by the Veerni Institute in India. When lockdowns hit, they were sent home to their villages, where child marriage is rampant. -
The World Health Organization has reported a downturn after 8 weeks of increasing cases. But the good news comes with a large dose of caution.
